Patents by Inventor Gabriel Charest

Gabriel Charest has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions comprising a radiosensitizer and an anti-cancer agent and methods of uses thereof
    Patent number: 9302003
    Abstract: A combination of an anti-cancer agent and a metal radiosensitizer potentiates the radiotherapy of cancer. Said anti-cancer agent is preferably cisplatin while the metal radiosensitizer is preferably gold nanoparticles. Both the anti-cancer agent and the metal radiosensitizer bind to DNA and potentiate the radiotherapy of cancer by synergistically increases the amount of double strand breaks induced by the radiation. The anti-cancer agent and the metal radiosensitizer may be encapsulated in liposomes.
    Type: Grant
    Filed: April 26, 2010
    Date of Patent: April 5, 2016
    Assignee: SOCPRA—SCIENCES SANTÉ´ET HUMAINES
    Inventors: Léon Sanche, Gabriel Charest
  • COMPOSITIONS COMPRISING A RADIOSENSITIZER AND AN ANTI-CANCER AGENT AND METHODS OF USES THEREOF
    Publication number: 20120093918
    Abstract: A combination of an anti-cancer agent and a metal radiosensitizer potentiates the radiotherapy of cancer. Said anti-cancer agent is preferably cisplatin while the metal radiosensitizer is preferably gold nanoparticles. Both the anti-cancer agent and the metal radiosensitizer bind to DNA and potentiate the radiotherapy of cancer by synergistically increases the amount of double strand breaks induced by the radiation. The anti-cancer agent and the metal radiosensitizer may be encapsulated in liposomes.
    Type: Application
    Filed: April 26, 2010
    Publication date: April 19, 2012
    Applicant: SOCPRA - SCIENCES SANTE ET HUMAINES
    Inventors: Léon Sanche, Gabriel Charest